Skip to content

WaveLight® Refractive Flap Accuracy Study

A Prospective, Global, Multi-Center Study to Evaluate Longitudinal Flap Accuracy on Subjects Undergoing Myopic Refractive Surgery Using the WaveLight® Refractive Suite

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01941485
Enrollment
60
Registered
2013-09-13
Start date
2013-10-31
Completion date
2015-02-28
Last updated
2017-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractive Error

Keywords

nearsighted, astigmatism, LASIK, refractive surgery, WaveLight

Brief summary

The purpose of this study is to evaluate the accuracy of the WaveLight FS200 femtosecond laser, as assessed by 1 day and 1 month post-operative optical coherence tomography (OCT) anterior segment corneal measurements compared to pre-operative flap thickness target.

Interventions

Excimer EX500 and Femtosecond FS200 lasers (Wavelight® Refractive Suite) used during LASIK surgery for corneal flap creation and corneal ablation

PROCEDURELASIK surgery

Surgical procedure for treating refractive error based on corneal reshaping

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Willing and able to understand and sign an informed consent form. * Have refractive error (in both eyes) that requires refractive surgery. * Willing to undergo LASIK surgery using the Wavelight® Refractive Suite. * Myopia between 0.00 to -12.0 Diopters pre-operatively. * Astigmatism between 0.00 to +6.00 Diopters pre-operatively. * Willing and able to attend post-operative examinations per protocol schedule. * Other protocol-defined inclusion criteria may apply.

Exclusion criteria

* Participation in a clinical study within the last 30 days. * History of previous corneal surgery in either eye. * Multifocal ablations in either eye. * PRK or PTK surgery in either eye. * Suffering from acute or recurring eye diseases in either eye, such as corneal ulcers, cataract, etc. * Any ocular disease and/or condition that, in the Investigator's clinical judgment, may put subject at significant risk, compromise study results, or interfere significantly with subject's participation in the study. * Unable to discontinue contact lens wear as specified in protocol. * History of Herpes simplex or Herpes zoster keratitis. * Active ocular rosacea. * Lyme disease. * Severe ocular allergies. * Other medical conditions and use of medications as specified in protocol. * Pregnant or planning to become pregnant during the study. * Other protocol-specified

Design outcomes

Primary

MeasureTime frameDescription
The Difference Between Achieved Flap Thickness at Day 1 Postoperative as Assessed by OCT and Expected Flap Thickness as Determined Pre-operativelyDay 1 PostoperativeThe expected flap thickness as determined pre-operatively was subtracted from the achieved flap thickness at Day 1 postoperative as assessed by optical coherence tomography (ie, an imaging method using light to capture three-dimensional images). Accuracy of flap creation was defined as an achieved thickness within 10 microns of expected thickness.

Secondary

MeasureTime frameDescription
Extent of Opaque Bubble Layer (OBL) Within the Femtosecond FlapOperation/Surgery (Day 1)The extent of OBL was assessed by digital photo analysis of the area covered by the flap and is reported as the percentage of flap with opaque bubble layer development during femtosecond flap creation.
The Difference Between Achieved Flap Thickness at Month 1 Post-operative as Assessed by OCT and Expected Flap Thickness as Determined PreoperativelyMonth 1 PostoperativeThe expected flap thickness as determined pre-operatively subtracted from the achieved flap thickness at Month 1 postoperative as assessed by optical coherence tomography (ie, an imaging method using light to capture three-dimensional images). Accuracy of flap creation was defined as an achieved thickness within 10 microns of expected thickness.
Uncorrected Visual Acuity (UCVA)Baseline/Screening (Day 0), Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 PostoperativeVisual acuity (VA) without spectacles or other visual corrective devices, was performed with an Early Treatment Diabetic Retinopathy Study (ETDRS) chart set at a distance of 4 meters. UCVA was measured in logMAR (logarithm of the minimum angle of resolution), with 0.00 logMAR corresponding to 20/20 Snellen. A lower logMAR value indicates better visual acuity.
Best Corrected Visual Acuity (BCVA)Baseline/Screening (Day 0), Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 PostoperativeVA with the subjects's best spectacles or other visual corrective devices, was performed with an ETDRS chart set at a distance of 4 meters. BCVA was measured in logMAR (logarithm of the minimum angle of resolution), with 0.00 logMAR corresponding to 20/20 Snellen. A lower logMAR value indicates better visual acuity.
Manifest Refraction (Sphere)Baseline/Screening (Day 0), Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 PostoperativeA series of test lenses in graded powers was used to determine which corrective lenses provided the sharpest, clearest vision. Manifest refraction is measured in diopters. Each eye contributed individually to the analysis.
Manifest Refraction (Cylinder)Baseline/Screening (Day 0), Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 PostoperativeA series of test lenses in graded powers was used to determine which corrective lenses provided the sharpest, clearest vision. Manifest refraction is measured in diopters. Each eye contributed individually to the analysis.
Mean Contrast Sensitivity (CS)Baseline/Screening (Day 0), Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 PostoperativeContrast sensitivity (ie, the ability to detect slight changes in luminance before they become indistinguishable) was assessed binocularly with distance manifest correction in place and uncorrected. Contrast sensitivity was assessed at spatial frequencies of 3, 6, 12, and 18 cycles per degree (cpd), where 3.0 cpd = A, 6.0 cpd = B, 12.0 cpd = C, and 18.0 cpd = D. Raw scores were log transformed. A higher numeric value represents better contrast sensitivity. Both eyes contributed to the analysis.
Corneal Flap Diameter as Assessed by Ocular Coherence Tomography (OCT)Operation/Surgery (Day 1), Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 PostoperativeThe diameter of the corneal flap was assessed by OCT (ie. an imaging method using light to capture three-dimensional images). Corneal flap is measured in millimeters.
Wavefront AberrometryOperation/Surgery (Day 1), Month 1 Postoperative, Month 6 Postoperative, Month 12 PostoperativeWavefront aberrations (optical imperfections of the eye that prevent light from focusing perfectly on the retina, resulting in defects in the visual image) were measured using a commercially available system. Higher order aberrations (i.e., spherical aberrations, coma, and trefoil) are defined as optical imperfections which cannot be corrected by any reliable means of present technology.
Percent Response by Category: Driving at NightBaseline/Screening (Day 0), Month 1 Postoperative, Month 6 Postoperative, Month 12 PostoperativeAs recorded by the subject on the RSVP questionnaire, where 0 is Not applicable, 1 is No difficulty at all, 2 is A little difficulty, 3 is Moderate difficulty, 4 is Severe difficulty and 5 is So much difficulty that I did not do the activity with this alternative.
Incidence of Development of Opaque Bubble Layer (OBL)Operation/Surgery (Day 1)OBL (the collection of gas bubbles during corneal flap creation) was assessed by digital photo analysis of the area covered by the flap and is reported as the percentage of participants with opaque bubble layer development during femtosecond flap creation.
Percent Response to Have Always Worn Glasses or Contact Lenses in the Past 4 WeeksBaseline/Screening (Day 0), Month 1 Postoperative, Month 6 Postoperative, Month 12 PostoperativeAs recorded by the subject on the the Refractive Status and Vision Profile (RSVP), a self-reported questionnaire used to measure vision-related health status in persons with refractive error.
Percent Response by Category: I Worry About my VisionBaseline/Screening (Day 0), Month 1 Postoperative, Month 6 Postoperative, Month 12 PostoperativeAs recorded by the subject on the RSVP questionnaire
Percent Response by Category: My Vision is a Concern in my Daily LifeBaseline/Screening (Day 0), Month 1 Postoperative, Month 6 Postoperative, Month 12 PostoperativeAs recorded by the subject on the RSVP questionnaire
Corneal Curvature as Measured by KeratometryBaseline/Screening (Day 0), 1 Month Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 PostoperativeCorneal curvature as assessed by a commercially available system and measured in diopters.
Flap Creation Time as Documented in the Log FilesOperation/Surgery (Day 1)The time to create the flap with FS200 Femtosecond Flap Creation System, measured in seconds.
Corneal Topography: Q-valueDay 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 PostoperativeThe Q-value (a measure of corneal asphericity) was assessed using a commercially available system. The Q-values are negative (-1 \< Q \< 0) for prolate corneas, in which the central curvature is steeper than the peripheral curvature, and positive (Q \> 0) for oblate corneas, in which the central curvature is flatter than the peripheral curvature.
Corneal Topography: Anterior Chamber (AC) VolumeDay 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 PostoperativeThe AC volume (a measure of the shallowness of the anterior chamber) was assessed using a commercially available system. The lower the chamber volume, the more shallow the anterior chamber or the chamber angle.
Corneal Topography: Anterior Chamber (AC) DepthDay 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 PostoperativeThe AC depth (axial distance between the anterior surface of the cornea and the anterior surface of the lens) was assessed using a commercially available system. A higher value represents a longer distance.
Corneal Topography: AnglesDay 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 PostoperativeThe angles (angular measurement of the space between the iris and the lens) were assessed using a commercially available system. The higher the value, the bigger the space.
Mean Response: Rate Your Vision, Over the Past 4 Weeks, With NO Glasses or Contact LensesBaseline/Screening (Day 0), Month 1 Postoperative, Month 6 Postoperative, Month 12 PostoperativeAs recorded by the subject on the the Refractive Status and Vision Profile (RSVP), a self-reported questionnaire used to measure vision-related health status in persons with refractive error, on a scale from 0 (completely blind) to 10 (perfect vision).

Participant flow

Recruitment details

Subjects were recruited from 1 study center located in the US and 1 study center located in Greece.

Pre-assignment details

Of the 60 enrolled subjects, 1 was exited as a screen failure prior to surgery. This reporting group includes all enrolled subjects who underwent LASIK surgery (59).

Participants by arm

ArmCount
WaveLight Refractive Suite
Excimer EX500 and Femtosecond FS200 lasers used during LASIK surgery for corneal flap creation and corneal ablation
59
Total59

Baseline characteristics

CharacteristicWaveLight Refractive Suite
Age, Continuous33.3 years
STANDARD_DEVIATION 9.22
Gender
Female
34 Participants
Gender
Male
25 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 59
serious
Total, serious adverse events
0 / 59

Outcome results

Primary

The Difference Between Achieved Flap Thickness at Day 1 Postoperative as Assessed by OCT and Expected Flap Thickness as Determined Pre-operatively

The expected flap thickness as determined pre-operatively was subtracted from the achieved flap thickness at Day 1 postoperative as assessed by optical coherence tomography (ie, an imaging method using light to capture three-dimensional images). Accuracy of flap creation was defined as an achieved thickness within 10 microns of expected thickness.

Time frame: Day 1 Postoperative

Population: This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint.

ArmMeasureGroupValue (MEAN)Dispersion
WaveLight Refractive SuiteThe Difference Between Achieved Flap Thickness at Day 1 Postoperative as Assessed by OCT and Expected Flap Thickness as Determined Pre-operativelyRight eye (OD)14.996 micronsStandard Deviation 12.7509
WaveLight Refractive SuiteThe Difference Between Achieved Flap Thickness at Day 1 Postoperative as Assessed by OCT and Expected Flap Thickness as Determined Pre-operativelyLeft eye (OS)13.644 micronsStandard Deviation 10.4762
Secondary

Best Corrected Visual Acuity (BCVA)

VA with the subjects's best spectacles or other visual corrective devices, was performed with an ETDRS chart set at a distance of 4 meters. BCVA was measured in logMAR (logarithm of the minimum angle of resolution), with 0.00 logMAR corresponding to 20/20 Snellen. A lower logMAR value indicates better visual acuity.

Time frame: Baseline/Screening (Day 0), Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative

Population: This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint.

ArmMeasureGroupValue (MEAN)Dispersion
WaveLight Refractive SuiteBest Corrected Visual Acuity (BCVA)Left eye (OS)-0.042 logMARStandard Deviation 0.0894
WaveLight Refractive SuiteBest Corrected Visual Acuity (BCVA)Right eye (OD)-0.046 logMARStandard Deviation 0.0855
WaveLight Refractive SuiteBest Corrected Visual Acuity (BCVA)Both eyes (OU)-0.063 logMARStandard Deviation 0.0814
Day 1 PostoperativeBest Corrected Visual Acuity (BCVA)Left eye (OS)-0.027 logMARStandard Deviation 0.0915
Day 1 PostoperativeBest Corrected Visual Acuity (BCVA)Right eye (OD)-0.028 logMARStandard Deviation 0.1097
Day 1 PostoperativeBest Corrected Visual Acuity (BCVA)Both eyes (OU)-0.051 logMARStandard Deviation 0.0973
Month 1 PostoperativeBest Corrected Visual Acuity (BCVA)Left eye (OS)-0.062 logMARStandard Deviation 0.0947
Month 1 PostoperativeBest Corrected Visual Acuity (BCVA)Right eye (OD)-0.064 logMARStandard Deviation 0.0953
Month 1 PostoperativeBest Corrected Visual Acuity (BCVA)Both eyes (OU)-0.096 logMARStandard Deviation 0.0907
Month 3 PostoperativeBest Corrected Visual Acuity (BCVA)Left eye (OS)-0.070 logMARStandard Deviation 0.0967
Month 3 PostoperativeBest Corrected Visual Acuity (BCVA)Right eye (OD)-0.072 logMARStandard Deviation 0.0877
Month 3 PostoperativeBest Corrected Visual Acuity (BCVA)Both eyes (OU)-0.099 logMARStandard Deviation 0.0863
Month 6 PostoperativeBest Corrected Visual Acuity (BCVA)Left eye (OS)-0.086 logMARStandard Deviation 0.0941
Month 6 PostoperativeBest Corrected Visual Acuity (BCVA)Right eye (OD)-0.091 logMARStandard Deviation 0.081
Month 6 PostoperativeBest Corrected Visual Acuity (BCVA)Both eyes (OU)-0.111 logMARStandard Deviation 0.087
Month 12 PostoperativeBest Corrected Visual Acuity (BCVA)Right eye (OD)-0.103 logMARStandard Deviation 0.088
Month 12 PostoperativeBest Corrected Visual Acuity (BCVA)Both eyes (OU)-0.148 logMARStandard Deviation 0.0837
Month 12 PostoperativeBest Corrected Visual Acuity (BCVA)Left eye (OS)-0.099 logMARStandard Deviation 0.0976
Secondary

Corneal Curvature as Measured by Keratometry

Corneal curvature as assessed by a commercially available system and measured in diopters.

Time frame: Baseline/Screening (Day 0), 1 Month Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative

Population: This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint.

ArmMeasureGroupValue (MEAN)Dispersion
WaveLight Refractive SuiteCorneal Curvature as Measured by KeratometryK2, Left Eye44.7 diopterStandard Deviation 1.78
WaveLight Refractive SuiteCorneal Curvature as Measured by KeratometryK1, Left Eye43.5 diopterStandard Deviation 1.74
WaveLight Refractive SuiteCorneal Curvature as Measured by KeratometryMean K1 and K2, Right Eye44.0 diopterStandard Deviation 1.6
WaveLight Refractive SuiteCorneal Curvature as Measured by KeratometryK1, Right Eye43.4 diopterStandard Deviation 1.58
WaveLight Refractive SuiteCorneal Curvature as Measured by KeratometryMean K1 and K2, Left Eye44.1 diopterStandard Deviation 1.72
WaveLight Refractive SuiteCorneal Curvature as Measured by KeratometryK2, Right Eye44.6 diopterStandard Deviation 1.69
Day 1 PostoperativeCorneal Curvature as Measured by KeratometryK2, Left Eye40.5 diopterStandard Deviation 2.49
Day 1 PostoperativeCorneal Curvature as Measured by KeratometryK1, Right Eye39.9 diopterStandard Deviation 2.42
Day 1 PostoperativeCorneal Curvature as Measured by KeratometryMean K1 and K2, Left Eye40.1 diopterStandard Deviation 2.42
Day 1 PostoperativeCorneal Curvature as Measured by KeratometryK1, Left Eye39.8 diopterStandard Deviation 2.37
Day 1 PostoperativeCorneal Curvature as Measured by KeratometryK2, Right Eye40.6 diopterStandard Deviation 2.59
Day 1 PostoperativeCorneal Curvature as Measured by KeratometryMean K1 and K2, Right Eye40.3 diopterStandard Deviation 2.47
Month 1 PostoperativeCorneal Curvature as Measured by KeratometryMean K1 and K2, Left Eye40.2 diopterStandard Deviation 2.25
Month 1 PostoperativeCorneal Curvature as Measured by KeratometryK2, Left Eye40.5 diopterStandard Deviation 2.32
Month 1 PostoperativeCorneal Curvature as Measured by KeratometryK2, Right Eye40.7 diopterStandard Deviation 2.52
Month 1 PostoperativeCorneal Curvature as Measured by KeratometryK1, Right Eye39.9 diopterStandard Deviation 2.43
Month 1 PostoperativeCorneal Curvature as Measured by KeratometryK1, Left Eye39.8 diopterStandard Deviation 2.2
Month 1 PostoperativeCorneal Curvature as Measured by KeratometryMean K1 and K2, Right Eye40.3 diopterStandard Deviation 2.46
Month 3 PostoperativeCorneal Curvature as Measured by KeratometryK2, Right Eye40.8 diopterStandard Deviation 2.51
Month 3 PostoperativeCorneal Curvature as Measured by KeratometryK1, Right Eye40.0 diopterStandard Deviation 2.36
Month 3 PostoperativeCorneal Curvature as Measured by KeratometryK1, Left Eye39.9 diopterStandard Deviation 2.31
Month 3 PostoperativeCorneal Curvature as Measured by KeratometryK2, Left Eye40.8 diopterStandard Deviation 2.37
Month 3 PostoperativeCorneal Curvature as Measured by KeratometryMean K1 and K2, Right Eye40.4 diopterStandard Deviation 2.42
Month 3 PostoperativeCorneal Curvature as Measured by KeratometryMean K1 and K2, Left Eye40.4 diopterStandard Deviation 2.33
Month 6 PostoperativeCorneal Curvature as Measured by KeratometryK1, Left Eye40.0 diopterStandard Deviation 2.26
Month 6 PostoperativeCorneal Curvature as Measured by KeratometryMean K1 and K2, Left Eye40.4 diopterStandard Deviation 2.3
Month 6 PostoperativeCorneal Curvature as Measured by KeratometryK1, Right Eye40.1 diopterStandard Deviation 2.34
Month 6 PostoperativeCorneal Curvature as Measured by KeratometryMean K1 and K2, Right Eye40.5 diopterStandard Deviation 2.39
Month 6 PostoperativeCorneal Curvature as Measured by KeratometryK2, Left Eye40.8 diopterStandard Deviation 2.35
Month 6 PostoperativeCorneal Curvature as Measured by KeratometryK2, Right Eye40.8 diopterStandard Deviation 2.47
Secondary

Corneal Flap Diameter as Assessed by Ocular Coherence Tomography (OCT)

The diameter of the corneal flap was assessed by OCT (ie. an imaging method using light to capture three-dimensional images). Corneal flap is measured in millimeters.

Time frame: Operation/Surgery (Day 1), Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative

Population: This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint.

ArmMeasureGroupValue (MEAN)Dispersion
WaveLight Refractive SuiteCorneal Flap Diameter as Assessed by Ocular Coherence Tomography (OCT)Right eye (OD)8.4 millimetersStandard Deviation 0.25
WaveLight Refractive SuiteCorneal Flap Diameter as Assessed by Ocular Coherence Tomography (OCT)Left eye (OS)8.4 millimetersStandard Deviation 0.27
Day 1 PostoperativeCorneal Flap Diameter as Assessed by Ocular Coherence Tomography (OCT)Right eye (OD)8.4 millimetersStandard Deviation 0.25
Day 1 PostoperativeCorneal Flap Diameter as Assessed by Ocular Coherence Tomography (OCT)Left eye (OS)8.4 millimetersStandard Deviation 0.27
Month 1 PostoperativeCorneal Flap Diameter as Assessed by Ocular Coherence Tomography (OCT)Right eye (OD)8.4 millimetersStandard Deviation 0.24
Month 1 PostoperativeCorneal Flap Diameter as Assessed by Ocular Coherence Tomography (OCT)Left eye (OS)8.4 millimetersStandard Deviation 0.26
Month 3 PostoperativeCorneal Flap Diameter as Assessed by Ocular Coherence Tomography (OCT)Right eye (OD)8.4 millimetersStandard Deviation 0.25
Month 3 PostoperativeCorneal Flap Diameter as Assessed by Ocular Coherence Tomography (OCT)Left eye (OS)8.4 millimetersStandard Deviation 0.27
Month 6 PostoperativeCorneal Flap Diameter as Assessed by Ocular Coherence Tomography (OCT)Right eye (OD)8.4 millimetersStandard Deviation 0.25
Month 6 PostoperativeCorneal Flap Diameter as Assessed by Ocular Coherence Tomography (OCT)Left eye (OS)8.4 millimetersStandard Deviation 0.27
Month 12 PostoperativeCorneal Flap Diameter as Assessed by Ocular Coherence Tomography (OCT)Right eye (OD)8.4 millimetersStandard Deviation 0.25
Month 12 PostoperativeCorneal Flap Diameter as Assessed by Ocular Coherence Tomography (OCT)Left eye (OS)8.4 millimetersStandard Deviation 0.27
Secondary

Corneal Topography: Angles

The angles (angular measurement of the space between the iris and the lens) were assessed using a commercially available system. The higher the value, the bigger the space.

Time frame: Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative

Population: This analysis population includes all subjects with 1 day post-operation measurements of the corneal topography endpoint. Here, n includes all eyes with data.

ArmMeasureGroupValue (MEAN)Dispersion
WaveLight Refractive SuiteCorneal Topography: AnglesDay 1 Postoperative, n=11641.07 degreesStandard Deviation 6.612
WaveLight Refractive SuiteCorneal Topography: AnglesMonth 1 Postoperative, n=11840.63 degreesStandard Deviation 6.155
WaveLight Refractive SuiteCorneal Topography: AnglesMonth 3 Postoperative, n=11841.09 degreesStandard Deviation 6.155
WaveLight Refractive SuiteCorneal Topography: AnglesMonth 6 Postoperative, n=11840.81 degreesStandard Deviation 6.141
WaveLight Refractive SuiteCorneal Topography: AnglesMonth 12 Postoperative, n=11840.74 degreesStandard Deviation 6.133
Secondary

Corneal Topography: Anterior Chamber (AC) Depth

The AC depth (axial distance between the anterior surface of the cornea and the anterior surface of the lens) was assessed using a commercially available system. A higher value represents a longer distance.

Time frame: Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative

Population: This analysis population includes all subjects with 1 day post-operation measurements of the corneal topography endpoint. Here, n includes all eyes with data.

ArmMeasureGroupValue (MEAN)Dispersion
WaveLight Refractive SuiteCorneal Topography: Anterior Chamber (AC) DepthMonth 12 Postoperative, n=1183.16 millimetersStandard Deviation 0.276
WaveLight Refractive SuiteCorneal Topography: Anterior Chamber (AC) DepthDay 1 Postoperative, n=1163.43 millimetersStandard Deviation 0.37
WaveLight Refractive SuiteCorneal Topography: Anterior Chamber (AC) DepthMonth 1 Postoperative, n=1173.43 millimetersStandard Deviation 0.349
WaveLight Refractive SuiteCorneal Topography: Anterior Chamber (AC) DepthMonth 3 Postoperative, n=1183.38 millimetersStandard Deviation 0.352
WaveLight Refractive SuiteCorneal Topography: Anterior Chamber (AC) DepthMonth 6 Postoperative, n=1183.18 millimetersStandard Deviation 0.272
Secondary

Corneal Topography: Anterior Chamber (AC) Volume

The AC volume (a measure of the shallowness of the anterior chamber) was assessed using a commercially available system. The lower the chamber volume, the more shallow the anterior chamber or the chamber angle.

Time frame: Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative

Population: This analysis population includes all subjects with 1 day post-operation measurements of the corneal topography endpoint. Here, n includes all eyes with data.

ArmMeasureGroupValue (MEAN)Dispersion
WaveLight Refractive SuiteCorneal Topography: Anterior Chamber (AC) VolumeDay 1 Postoperative, n=116189.98 millimeters cubedStandard Deviation 30.439
WaveLight Refractive SuiteCorneal Topography: Anterior Chamber (AC) VolumeMonth 1 Postoperative, n=118195.25 millimeters cubedStandard Deviation 32.134
WaveLight Refractive SuiteCorneal Topography: Anterior Chamber (AC) VolumeMonth 3 Postoperative, n=118192.91 millimeters cubedStandard Deviation 31.156
WaveLight Refractive SuiteCorneal Topography: Anterior Chamber (AC) VolumeMonth 6 Postoperative, n=118191.92 millimeters cubedStandard Deviation 32.985
WaveLight Refractive SuiteCorneal Topography: Anterior Chamber (AC) VolumeMonth 12 Postoperative, n=118192.64 millimeters cubedStandard Deviation 33.382
Secondary

Corneal Topography: Q-value

The Q-value (a measure of corneal asphericity) was assessed using a commercially available system. The Q-values are negative (-1 \< Q \< 0) for prolate corneas, in which the central curvature is steeper than the peripheral curvature, and positive (Q \> 0) for oblate corneas, in which the central curvature is flatter than the peripheral curvature.

Time frame: Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative

Population: This analysis population includes all subjects with 1 day post-operation measurements of the corneal topography endpoint. Here, n includes all eyes with data.

ArmMeasureGroupValue (MEAN)Dispersion
WaveLight Refractive SuiteCorneal Topography: Q-valueDay 1 Postoperative, n=116-0.30 unit lessStandard Deviation 0.661
WaveLight Refractive SuiteCorneal Topography: Q-valueMonth 1 Postoperative, n=118-0.31 unit lessStandard Deviation 0.652
WaveLight Refractive SuiteCorneal Topography: Q-valueMonth 3 Postoperative, n=118-0.06 unit lessStandard Deviation 0.769
WaveLight Refractive SuiteCorneal Topography: Q-valueMonth 6 Postoperative, n=1180.10 unit lessStandard Deviation 0.752
WaveLight Refractive SuiteCorneal Topography: Q-valueMonth 12 Postoperative, n=1180.02 unit lessStandard Deviation 0.748
Secondary

Extent of Opaque Bubble Layer (OBL) Within the Femtosecond Flap

The extent of OBL was assessed by digital photo analysis of the area covered by the flap and is reported as the percentage of flap with opaque bubble layer development during femtosecond flap creation.

Time frame: Operation/Surgery (Day 1)

Population: This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint.

ArmMeasureGroupValue (MEAN)Dispersion
WaveLight Refractive SuiteExtent of Opaque Bubble Layer (OBL) Within the Femtosecond FlapRight eye (OD)8.9 percentage of flapStandard Deviation 7.59
WaveLight Refractive SuiteExtent of Opaque Bubble Layer (OBL) Within the Femtosecond FlapLeft eye (OS)11.1 percentage of flapStandard Deviation 6.94
Secondary

Flap Creation Time as Documented in the Log Files

The time to create the flap with FS200 Femtosecond Flap Creation System, measured in seconds.

Time frame: Operation/Surgery (Day 1)

Population: This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint.

ArmMeasureGroupValue (MEAN)Dispersion
WaveLight Refractive SuiteFlap Creation Time as Documented in the Log FilesRight eye (OD)34.864 secondsStandard Deviation 7.3001
WaveLight Refractive SuiteFlap Creation Time as Documented in the Log FilesLeft eye (OS)33.220 secondsStandard Deviation 7.755
Secondary

Incidence of Development of Opaque Bubble Layer (OBL)

OBL (the collection of gas bubbles during corneal flap creation) was assessed by digital photo analysis of the area covered by the flap and is reported as the percentage of participants with opaque bubble layer development during femtosecond flap creation.

Time frame: Operation/Surgery (Day 1)

Population: This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint.

ArmMeasureGroupValue (NUMBER)
WaveLight Refractive SuiteIncidence of Development of Opaque Bubble Layer (OBL)Right eye (OD)20.3 percentage of participants
WaveLight Refractive SuiteIncidence of Development of Opaque Bubble Layer (OBL)Left eye (OS)35.6 percentage of participants
Secondary

Manifest Refraction (Cylinder)

A series of test lenses in graded powers was used to determine which corrective lenses provided the sharpest, clearest vision. Manifest refraction is measured in diopters. Each eye contributed individually to the analysis.

Time frame: Baseline/Screening (Day 0), Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative

Population: This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint.

ArmMeasureGroupValue (MEAN)Dispersion
WaveLight Refractive SuiteManifest Refraction (Cylinder)Month 1 Postoperative-0.15 DioptersStandard Deviation 0.236
WaveLight Refractive SuiteManifest Refraction (Cylinder)Baseline/Screening (Day 0)-0.95 DioptersStandard Deviation 0.847
WaveLight Refractive SuiteManifest Refraction (Cylinder)Month 3 Postoperative-0.15 DioptersStandard Deviation 0.251
WaveLight Refractive SuiteManifest Refraction (Cylinder)Month 6 Postoperative-0.16 DioptersStandard Deviation 0.242
WaveLight Refractive SuiteManifest Refraction (Cylinder)Month 12 Postoperative-0.17 DioptersStandard Deviation 0.323
Secondary

Manifest Refraction (Sphere)

A series of test lenses in graded powers was used to determine which corrective lenses provided the sharpest, clearest vision. Manifest refraction is measured in diopters. Each eye contributed individually to the analysis.

Time frame: Baseline/Screening (Day 0), Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative

Population: This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint.

ArmMeasureGroupValue (MEAN)Dispersion
WaveLight Refractive SuiteManifest Refraction (Sphere)Baseline/Screening (Day 0)-4.254 DioptersStandard Deviation 2.334
WaveLight Refractive SuiteManifest Refraction (Sphere)Day 1 Postoperative-0.347 DioptersStandard Deviation 0.4174
WaveLight Refractive SuiteManifest Refraction (Sphere)Month 1 Postoperative-0.186 DioptersStandard Deviation 0.3304
WaveLight Refractive SuiteManifest Refraction (Sphere)Month 3 Postoperative-0.153 DioptersStandard Deviation 0.3049
WaveLight Refractive SuiteManifest Refraction (Sphere)Month 6 Postoperative-0.167 DioptersStandard Deviation 0.3253
WaveLight Refractive SuiteManifest Refraction (Sphere)Month 12 Postoperative-0.165 DioptersStandard Deviation 0.319
Secondary

Mean Contrast Sensitivity (CS)

Contrast sensitivity (ie, the ability to detect slight changes in luminance before they become indistinguishable) was assessed binocularly with distance manifest correction in place and uncorrected. Contrast sensitivity was assessed at spatial frequencies of 3, 6, 12, and 18 cycles per degree (cpd), where 3.0 cpd = A, 6.0 cpd = B, 12.0 cpd = C, and 18.0 cpd = D. Raw scores were log transformed. A higher numeric value represents better contrast sensitivity. Both eyes contributed to the analysis.

Time frame: Baseline/Screening (Day 0), Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative

Population: This analysis population includes all subjects with 1 month post-operative measurements of the primary efficacy endpoint with data at the specific time point.

ArmMeasureGroupValue (MEAN)Dispersion
WaveLight Refractive SuiteMean Contrast Sensitivity (CS)CS A (corrected), n=59, 59, 59, 59, 591.970 logCSStandard Deviation 0.1576
WaveLight Refractive SuiteMean Contrast Sensitivity (CS)CS D (uncorrected), n=29, 58, 57, 56, 580.321 logCSStandard Deviation 0.5745
WaveLight Refractive SuiteMean Contrast Sensitivity (CS)CS C (uncorrected), n=28, 59, 58, 59, 580.687 logCSStandard Deviation 0.4789
WaveLight Refractive SuiteMean Contrast Sensitivity (CS)CS C (corrected), n=57, 58, 57, 56, 581.262 logCSStandard Deviation 0.2657
WaveLight Refractive SuiteMean Contrast Sensitivity (CS)CS C (corrected), n=59, 59, 58, 59, 581.706 logCSStandard Deviation 0.2716
WaveLight Refractive SuiteMean Contrast Sensitivity (CS)CS A (uncorrected), n=31, 59, 59, 59, 590.872 logCSStandard Deviation 0.5604
WaveLight Refractive SuiteMean Contrast Sensitivity (CS)CS B (corrected), n=59, 59, 59, 59, 592.074 logCSStandard Deviation 0.1779
WaveLight Refractive SuiteMean Contrast Sensitivity (CS)CS B (uncorrected), n=30, 59, 59, 59, 590.986 logCSStandard Deviation 0.4934
Day 1 PostoperativeMean Contrast Sensitivity (CS)CS C (corrected), n=59, 59, 58, 59, 581.815 logCSStandard Deviation 0.2017
Day 1 PostoperativeMean Contrast Sensitivity (CS)CS C (corrected), n=57, 58, 57, 56, 581.338 logCSStandard Deviation 0.2713
Day 1 PostoperativeMean Contrast Sensitivity (CS)CS B (uncorrected), n=30, 59, 59, 59, 592.080 logCSStandard Deviation 0.1427
Day 1 PostoperativeMean Contrast Sensitivity (CS)CS C (uncorrected), n=28, 59, 58, 59, 581.802 logCSStandard Deviation 0.2096
Day 1 PostoperativeMean Contrast Sensitivity (CS)CS A (uncorrected), n=31, 59, 59, 59, 591.996 logCSStandard Deviation 0.1219
Day 1 PostoperativeMean Contrast Sensitivity (CS)CS D (uncorrected), n=29, 58, 57, 56, 581.317 logCSStandard Deviation 0.2619
Day 1 PostoperativeMean Contrast Sensitivity (CS)CS A (corrected), n=59, 59, 59, 59, 591.993 logCSStandard Deviation 0.131
Day 1 PostoperativeMean Contrast Sensitivity (CS)CS B (corrected), n=59, 59, 59, 59, 592.112 logCSStandard Deviation 0.1502
Month 1 PostoperativeMean Contrast Sensitivity (CS)CS B (uncorrected), n=30, 59, 59, 59, 592.087 logCSStandard Deviation 0.1571
Month 1 PostoperativeMean Contrast Sensitivity (CS)CS D (uncorrected), n=29, 58, 57, 56, 581.321 logCSStandard Deviation 0.2485
Month 1 PostoperativeMean Contrast Sensitivity (CS)CS C (corrected), n=59, 59, 58, 59, 581.813 logCSStandard Deviation 0.197
Month 1 PostoperativeMean Contrast Sensitivity (CS)CS B (corrected), n=59, 59, 59, 59, 592.100 logCSStandard Deviation 0.1424
Month 1 PostoperativeMean Contrast Sensitivity (CS)CS C (uncorrected), n=28, 59, 58, 59, 581.802 logCSStandard Deviation 0.2009
Month 1 PostoperativeMean Contrast Sensitivity (CS)CS A (corrected), n=59, 59, 59, 59, 592.003 logCSStandard Deviation 0.0967
Month 1 PostoperativeMean Contrast Sensitivity (CS)CS A (uncorrected), n=31, 59, 59, 59, 591.971 logCSStandard Deviation 0.1249
Month 1 PostoperativeMean Contrast Sensitivity (CS)CS C (corrected), n=57, 58, 57, 56, 581.332 logCSStandard Deviation 0.2491
Month 3 PostoperativeMean Contrast Sensitivity (CS)CS B (uncorrected), n=30, 59, 59, 59, 592.148 logCSStandard Deviation 0.1428
Month 3 PostoperativeMean Contrast Sensitivity (CS)CS D (uncorrected), n=29, 58, 57, 56, 581.369 logCSStandard Deviation 0.2517
Month 3 PostoperativeMean Contrast Sensitivity (CS)CS C (corrected), n=59, 59, 58, 59, 581.848 logCSStandard Deviation 0.2211
Month 3 PostoperativeMean Contrast Sensitivity (CS)CS A (corrected), n=59, 59, 59, 59, 592.025 logCSStandard Deviation 0.1424
Month 3 PostoperativeMean Contrast Sensitivity (CS)CS A (uncorrected), n=31, 59, 59, 59, 592.006 logCSStandard Deviation 0.1585
Month 3 PostoperativeMean Contrast Sensitivity (CS)CS C (corrected), n=57, 58, 57, 56, 581.388 logCSStandard Deviation 0.2501
Month 3 PostoperativeMean Contrast Sensitivity (CS)CS C (uncorrected), n=28, 59, 58, 59, 581.833 logCSStandard Deviation 0.2259
Month 3 PostoperativeMean Contrast Sensitivity (CS)CS B (corrected), n=59, 59, 59, 59, 592.180 logCSStandard Deviation 0.1243
Month 6 PostoperativeMean Contrast Sensitivity (CS)CS C (corrected), n=57, 58, 57, 56, 581.422 logCSStandard Deviation 0.2292
Month 6 PostoperativeMean Contrast Sensitivity (CS)CS A (uncorrected), n=31, 59, 59, 59, 592.046 logCSStandard Deviation 0.146
Month 6 PostoperativeMean Contrast Sensitivity (CS)CS C (uncorrected), n=28, 59, 58, 59, 581.866 logCSStandard Deviation 0.1727
Month 6 PostoperativeMean Contrast Sensitivity (CS)CS D (uncorrected), n=29, 58, 57, 56, 581.396 logCSStandard Deviation 0.2379
Month 6 PostoperativeMean Contrast Sensitivity (CS)CS A (corrected), n=59, 59, 59, 59, 592.076 logCSStandard Deviation 0.1126
Month 6 PostoperativeMean Contrast Sensitivity (CS)CS B (corrected), n=59, 59, 59, 59, 592.172 logCSStandard Deviation 0.1545
Month 6 PostoperativeMean Contrast Sensitivity (CS)CS C (corrected), n=59, 59, 58, 59, 581.897 logCSStandard Deviation 0.1538
Month 6 PostoperativeMean Contrast Sensitivity (CS)CS B (uncorrected), n=30, 59, 59, 59, 592.163 logCSStandard Deviation 0.1588
Secondary

Mean Response: Rate Your Vision, Over the Past 4 Weeks, With NO Glasses or Contact Lenses

As recorded by the subject on the the Refractive Status and Vision Profile (RSVP), a self-reported questionnaire used to measure vision-related health status in persons with refractive error, on a scale from 0 (completely blind) to 10 (perfect vision).

Time frame: Baseline/Screening (Day 0), Month 1 Postoperative, Month 6 Postoperative, Month 12 Postoperative

Population: This analysis population includes all subjects with 1 month post-operative measurements of the primary efficacy endpoint with data at the specific time point.

ArmMeasureValue (MEAN)Dispersion
WaveLight Refractive SuiteMean Response: Rate Your Vision, Over the Past 4 Weeks, With NO Glasses or Contact Lenses2.7 units on a scaleStandard Deviation 1.42
Day 1 PostoperativeMean Response: Rate Your Vision, Over the Past 4 Weeks, With NO Glasses or Contact Lenses9.0 units on a scaleStandard Deviation 1.03
Month 1 PostoperativeMean Response: Rate Your Vision, Over the Past 4 Weeks, With NO Glasses or Contact Lenses9.3 units on a scaleStandard Deviation 0.82
Month 3 PostoperativeMean Response: Rate Your Vision, Over the Past 4 Weeks, With NO Glasses or Contact Lenses9.2 units on a scaleStandard Deviation 1.06
Secondary

Percent Response by Category: Driving at Night

As recorded by the subject on the RSVP questionnaire, where 0 is Not applicable, 1 is No difficulty at all, 2 is A little difficulty, 3 is Moderate difficulty, 4 is Severe difficulty and 5 is So much difficulty that I did not do the activity with this alternative.

Time frame: Baseline/Screening (Day 0), Month 1 Postoperative, Month 6 Postoperative, Month 12 Postoperative

Population: This analysis population includes all subjects with 1 month post-operative measurements of the primary efficacy endpoint with data at the specific time point.

ArmMeasureGroupValue (NUMBER)
WaveLight Refractive SuitePercent Response by Category: Driving at NightWithout glasses/contact lenses, 10.0 percentage of subjects
WaveLight Refractive SuitePercent Response by Category: Driving at NightWith contact lenses, 049.1 percentage of subjects
WaveLight Refractive SuitePercent Response by Category: Driving at NightWithout glasses/contact lenses, 547.4 percentage of subjects
WaveLight Refractive SuitePercent Response by Category: Driving at NightWith contact lenses, 31.8 percentage of subjects
WaveLight Refractive SuitePercent Response by Category: Driving at NightWith contact lenses, 135.1 percentage of subjects
WaveLight Refractive SuitePercent Response by Category: Driving at NightWith contact lenses, 212.3 percentage of subjects
WaveLight Refractive SuitePercent Response by Category: Driving at NightWithout glasses/contact lenses, 20.0 percentage of subjects
WaveLight Refractive SuitePercent Response by Category: Driving at NightWith glasses, 03.5 percentage of subjects
WaveLight Refractive SuitePercent Response by Category: Driving at NightWithout glasses/contact lenses, 31.8 percentage of subjects
WaveLight Refractive SuitePercent Response by Category: Driving at NightWithout glasses/contact lenses, 033.3 percentage of subjects
WaveLight Refractive SuitePercent Response by Category: Driving at NightWith glasses, 142.1 percentage of subjects
WaveLight Refractive SuitePercent Response by Category: Driving at NightWith glasses, 240.4 percentage of subjects
WaveLight Refractive SuitePercent Response by Category: Driving at NightWithout glasses/contact lenses, 417.5 percentage of subjects
WaveLight Refractive SuitePercent Response by Category: Driving at NightWith contact lenses, 51.8 percentage of subjects
WaveLight Refractive SuitePercent Response by Category: Driving at NightWith glasses, 37.0 percentage of subjects
WaveLight Refractive SuitePercent Response by Category: Driving at NightWith glasses, 45.3 percentage of subjects
WaveLight Refractive SuitePercent Response by Category: Driving at NightWith contact lenses, 40.0 percentage of subjects
WaveLight Refractive SuitePercent Response by Category: Driving at NightWith glasses, 51.8 percentage of subjects
Day 1 PostoperativePercent Response by Category: Driving at NightWithout glasses/contact lenses, 41.7 percentage of subjects
Day 1 PostoperativePercent Response by Category: Driving at NightWith contact lenses, 30.0 percentage of subjects
Day 1 PostoperativePercent Response by Category: Driving at NightWith glasses, 10.0 percentage of subjects
Day 1 PostoperativePercent Response by Category: Driving at NightWith contact lenses, 0100.0 percentage of subjects
Day 1 PostoperativePercent Response by Category: Driving at NightWithout glasses/contact lenses, 36.8 percentage of subjects
Day 1 PostoperativePercent Response by Category: Driving at NightWith contact lenses, 50.0 percentage of subjects
Day 1 PostoperativePercent Response by Category: Driving at NightWith contact lenses, 40.0 percentage of subjects
Day 1 PostoperativePercent Response by Category: Driving at NightWith contact lenses, 10.0 percentage of subjects
Day 1 PostoperativePercent Response by Category: Driving at NightWithout glasses/contact lenses, 50.0 percentage of subjects
Day 1 PostoperativePercent Response by Category: Driving at NightWith contact lenses, 20.0 percentage of subjects
Day 1 PostoperativePercent Response by Category: Driving at NightWith glasses, 20.0 percentage of subjects
Day 1 PostoperativePercent Response by Category: Driving at NightWithout glasses/contact lenses, 166.1 percentage of subjects
Day 1 PostoperativePercent Response by Category: Driving at NightWithout glasses/contact lenses, 06.8 percentage of subjects
Day 1 PostoperativePercent Response by Category: Driving at NightWith glasses, 50.0 percentage of subjects
Day 1 PostoperativePercent Response by Category: Driving at NightWith glasses, 40.0 percentage of subjects
Day 1 PostoperativePercent Response by Category: Driving at NightWith glasses, 0100.0 percentage of subjects
Day 1 PostoperativePercent Response by Category: Driving at NightWithout glasses/contact lenses, 218.6 percentage of subjects
Day 1 PostoperativePercent Response by Category: Driving at NightWith glasses, 30.0 percentage of subjects
Month 1 PostoperativePercent Response by Category: Driving at NightWithout glasses/contact lenses, 213.6 percentage of subjects
Month 1 PostoperativePercent Response by Category: Driving at NightWithout glasses/contact lenses, 40.0 percentage of subjects
Month 1 PostoperativePercent Response by Category: Driving at NightWithout glasses/contact lenses, 50.0 percentage of subjects
Month 1 PostoperativePercent Response by Category: Driving at NightWith glasses, 0100.0 percentage of subjects
Month 1 PostoperativePercent Response by Category: Driving at NightWith glasses, 10.0 percentage of subjects
Month 1 PostoperativePercent Response by Category: Driving at NightWith glasses, 20.0 percentage of subjects
Month 1 PostoperativePercent Response by Category: Driving at NightWith glasses, 30.0 percentage of subjects
Month 1 PostoperativePercent Response by Category: Driving at NightWith glasses, 40.0 percentage of subjects
Month 1 PostoperativePercent Response by Category: Driving at NightWith glasses, 50.0 percentage of subjects
Month 1 PostoperativePercent Response by Category: Driving at NightWith contact lenses, 0100.0 percentage of subjects
Month 1 PostoperativePercent Response by Category: Driving at NightWith contact lenses, 10.0 percentage of subjects
Month 1 PostoperativePercent Response by Category: Driving at NightWith contact lenses, 20.0 percentage of subjects
Month 1 PostoperativePercent Response by Category: Driving at NightWith contact lenses, 30.0 percentage of subjects
Month 1 PostoperativePercent Response by Category: Driving at NightWith contact lenses, 40.0 percentage of subjects
Month 1 PostoperativePercent Response by Category: Driving at NightWith contact lenses, 50.0 percentage of subjects
Month 1 PostoperativePercent Response by Category: Driving at NightWithout glasses/contact lenses, 05.1 percentage of subjects
Month 1 PostoperativePercent Response by Category: Driving at NightWithout glasses/contact lenses, 176.3 percentage of subjects
Month 1 PostoperativePercent Response by Category: Driving at NightWithout glasses/contact lenses, 35.1 percentage of subjects
Month 3 PostoperativePercent Response by Category: Driving at NightWith glasses, 40.0 percentage of subjects
Month 3 PostoperativePercent Response by Category: Driving at NightWith glasses, 30.0 percentage of subjects
Month 3 PostoperativePercent Response by Category: Driving at NightWithout glasses/contact lenses, 26.8 percentage of subjects
Month 3 PostoperativePercent Response by Category: Driving at NightWith contact lenses, 40.0 percentage of subjects
Month 3 PostoperativePercent Response by Category: Driving at NightWith glasses, 20.0 percentage of subjects
Month 3 PostoperativePercent Response by Category: Driving at NightWith glasses, 10.0 percentage of subjects
Month 3 PostoperativePercent Response by Category: Driving at NightWithout glasses/contact lenses, 33.4 percentage of subjects
Month 3 PostoperativePercent Response by Category: Driving at NightWith contact lenses, 50.0 percentage of subjects
Month 3 PostoperativePercent Response by Category: Driving at NightWith glasses, 0100.0 percentage of subjects
Month 3 PostoperativePercent Response by Category: Driving at NightWithout glasses/contact lenses, 51.7 percentage of subjects
Month 3 PostoperativePercent Response by Category: Driving at NightWithout glasses/contact lenses, 179.7 percentage of subjects
Month 3 PostoperativePercent Response by Category: Driving at NightWith contact lenses, 10.0 percentage of subjects
Month 3 PostoperativePercent Response by Category: Driving at NightWithout glasses/contact lenses, 05.1 percentage of subjects
Month 3 PostoperativePercent Response by Category: Driving at NightWith contact lenses, 20.0 percentage of subjects
Month 3 PostoperativePercent Response by Category: Driving at NightWith contact lenses, 0100.0 percentage of subjects
Month 3 PostoperativePercent Response by Category: Driving at NightWith glasses, 50.0 percentage of subjects
Month 3 PostoperativePercent Response by Category: Driving at NightWithout glasses/contact lenses, 43.4 percentage of subjects
Month 3 PostoperativePercent Response by Category: Driving at NightWith contact lenses, 30.0 percentage of subjects
Secondary

Percent Response by Category: I Worry About my Vision

As recorded by the subject on the RSVP questionnaire

Time frame: Baseline/Screening (Day 0), Month 1 Postoperative, Month 6 Postoperative, Month 12 Postoperative

Population: This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint.

ArmMeasureGroupValue (NUMBER)
WaveLight Refractive SuitePercent Response by Category: I Worry About my VisionRarely33.9 percentage of subjects
WaveLight Refractive SuitePercent Response by Category: I Worry About my VisionNever15.3 percentage of subjects
WaveLight Refractive SuitePercent Response by Category: I Worry About my VisionAlways1.7 percentage of subjects
WaveLight Refractive SuitePercent Response by Category: I Worry About my VisionSometimes32.2 percentage of subjects
WaveLight Refractive SuitePercent Response by Category: I Worry About my VisionOften16.9 percentage of subjects
Day 1 PostoperativePercent Response by Category: I Worry About my VisionSometimes8.5 percentage of subjects
Day 1 PostoperativePercent Response by Category: I Worry About my VisionOften8.5 percentage of subjects
Day 1 PostoperativePercent Response by Category: I Worry About my VisionAlways1.7 percentage of subjects
Day 1 PostoperativePercent Response by Category: I Worry About my VisionNever27.1 percentage of subjects
Day 1 PostoperativePercent Response by Category: I Worry About my VisionRarely54.2 percentage of subjects
Month 1 PostoperativePercent Response by Category: I Worry About my VisionSometimes11.9 percentage of subjects
Month 1 PostoperativePercent Response by Category: I Worry About my VisionNever50.8 percentage of subjects
Month 1 PostoperativePercent Response by Category: I Worry About my VisionRarely30.5 percentage of subjects
Month 1 PostoperativePercent Response by Category: I Worry About my VisionOften5.1 percentage of subjects
Month 1 PostoperativePercent Response by Category: I Worry About my VisionAlways1.7 percentage of subjects
Month 3 PostoperativePercent Response by Category: I Worry About my VisionOften5.1 percentage of subjects
Month 3 PostoperativePercent Response by Category: I Worry About my VisionRarely23.7 percentage of subjects
Month 3 PostoperativePercent Response by Category: I Worry About my VisionNever55.9 percentage of subjects
Month 3 PostoperativePercent Response by Category: I Worry About my VisionSometimes13.6 percentage of subjects
Month 3 PostoperativePercent Response by Category: I Worry About my VisionAlways1.7 percentage of subjects
Secondary

Percent Response by Category: My Vision is a Concern in my Daily Life

As recorded by the subject on the RSVP questionnaire

Time frame: Baseline/Screening (Day 0), Month 1 Postoperative, Month 6 Postoperative, Month 12 Postoperative

Population: This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint.

ArmMeasureGroupValue (NUMBER)
WaveLight Refractive SuitePercent Response by Category: My Vision is a Concern in my Daily LifeOften8.5 percentage of subjects
WaveLight Refractive SuitePercent Response by Category: My Vision is a Concern in my Daily LifeRarely28.8 percentage of subjects
WaveLight Refractive SuitePercent Response by Category: My Vision is a Concern in my Daily LifeAlways25.4 percentage of subjects
WaveLight Refractive SuitePercent Response by Category: My Vision is a Concern in my Daily LifeSometimes33.9 percentage of subjects
WaveLight Refractive SuitePercent Response by Category: My Vision is a Concern in my Daily LifeNever3.4 percentage of subjects
Day 1 PostoperativePercent Response by Category: My Vision is a Concern in my Daily LifeSometimes6.8 percentage of subjects
Day 1 PostoperativePercent Response by Category: My Vision is a Concern in my Daily LifeOften6.8 percentage of subjects
Day 1 PostoperativePercent Response by Category: My Vision is a Concern in my Daily LifeAlways10.2 percentage of subjects
Day 1 PostoperativePercent Response by Category: My Vision is a Concern in my Daily LifeRarely49.2 percentage of subjects
Day 1 PostoperativePercent Response by Category: My Vision is a Concern in my Daily LifeNever27.1 percentage of subjects
Month 1 PostoperativePercent Response by Category: My Vision is a Concern in my Daily LifeSometimes5.1 percentage of subjects
Month 1 PostoperativePercent Response by Category: My Vision is a Concern in my Daily LifeNever44.1 percentage of subjects
Month 1 PostoperativePercent Response by Category: My Vision is a Concern in my Daily LifeRarely30.5 percentage of subjects
Month 1 PostoperativePercent Response by Category: My Vision is a Concern in my Daily LifeOften3.4 percentage of subjects
Month 1 PostoperativePercent Response by Category: My Vision is a Concern in my Daily LifeAlways16.9 percentage of subjects
Month 3 PostoperativePercent Response by Category: My Vision is a Concern in my Daily LifeOften6.8 percentage of subjects
Month 3 PostoperativePercent Response by Category: My Vision is a Concern in my Daily LifeRarely22.0 percentage of subjects
Month 3 PostoperativePercent Response by Category: My Vision is a Concern in my Daily LifeNever50.8 percentage of subjects
Month 3 PostoperativePercent Response by Category: My Vision is a Concern in my Daily LifeSometimes6.8 percentage of subjects
Month 3 PostoperativePercent Response by Category: My Vision is a Concern in my Daily LifeAlways13.6 percentage of subjects
Secondary

Percent Response to Have Always Worn Glasses or Contact Lenses in the Past 4 Weeks

As recorded by the subject on the the Refractive Status and Vision Profile (RSVP), a self-reported questionnaire used to measure vision-related health status in persons with refractive error.

Time frame: Baseline/Screening (Day 0), Month 1 Postoperative, Month 6 Postoperative, Month 12 Postoperative

Population: This analysis population includes all subjects with 1 month post-operative measurements of the primary efficacy endpoint.

ArmMeasureGroupValue (NUMBER)
WaveLight Refractive SuitePercent Response to Have Always Worn Glasses or Contact Lenses in the Past 4 WeeksNo67.8 percentage of subjects
WaveLight Refractive SuitePercent Response to Have Always Worn Glasses or Contact Lenses in the Past 4 WeeksYes32.2 percentage of subjects
Day 1 PostoperativePercent Response to Have Always Worn Glasses or Contact Lenses in the Past 4 WeeksYes0.0 percentage of subjects
Day 1 PostoperativePercent Response to Have Always Worn Glasses or Contact Lenses in the Past 4 WeeksNo100.0 percentage of subjects
Month 1 PostoperativePercent Response to Have Always Worn Glasses or Contact Lenses in the Past 4 WeeksNo100.0 percentage of subjects
Month 1 PostoperativePercent Response to Have Always Worn Glasses or Contact Lenses in the Past 4 WeeksYes0.0 percentage of subjects
Month 3 PostoperativePercent Response to Have Always Worn Glasses or Contact Lenses in the Past 4 WeeksNo100.0 percentage of subjects
Month 3 PostoperativePercent Response to Have Always Worn Glasses or Contact Lenses in the Past 4 WeeksYes0.0 percentage of subjects
Secondary

The Difference Between Achieved Flap Thickness at Month 1 Post-operative as Assessed by OCT and Expected Flap Thickness as Determined Preoperatively

The expected flap thickness as determined pre-operatively subtracted from the achieved flap thickness at Month 1 postoperative as assessed by optical coherence tomography (ie, an imaging method using light to capture three-dimensional images). Accuracy of flap creation was defined as an achieved thickness within 10 microns of expected thickness.

Time frame: Month 1 Postoperative

Population: This analysis population includes all subjects with 1 month post-operative measurements of the primary efficacy endpoint with data at the specific time point.

ArmMeasureGroupValue (MEAN)Dispersion
WaveLight Refractive SuiteThe Difference Between Achieved Flap Thickness at Month 1 Post-operative as Assessed by OCT and Expected Flap Thickness as Determined PreoperativelyRight eye (OD)8.638 micronsStandard Deviation 5.5177
WaveLight Refractive SuiteThe Difference Between Achieved Flap Thickness at Month 1 Post-operative as Assessed by OCT and Expected Flap Thickness as Determined PreoperativelyLeft eye (OS)8.207 micronsStandard Deviation 4.7564
Secondary

Uncorrected Visual Acuity (UCVA)

Visual acuity (VA) without spectacles or other visual corrective devices, was performed with an Early Treatment Diabetic Retinopathy Study (ETDRS) chart set at a distance of 4 meters. UCVA was measured in logMAR (logarithm of the minimum angle of resolution), with 0.00 logMAR corresponding to 20/20 Snellen. A lower logMAR value indicates better visual acuity.

Time frame: Baseline/Screening (Day 0), Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative

Population: This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint.

ArmMeasureGroupValue (MEAN)Dispersion
WaveLight Refractive SuiteUncorrected Visual Acuity (UCVA)Left eye (OS)1.086 logMARStandard Deviation 0.3849
WaveLight Refractive SuiteUncorrected Visual Acuity (UCVA)Both eyes (OU)1.024 logMARStandard Deviation 0.4289
WaveLight Refractive SuiteUncorrected Visual Acuity (UCVA)Right eye (OD)1.078 logMARStandard Deviation 0.4042
Day 1 PostoperativeUncorrected Visual Acuity (UCVA)Both eyes (OU)-0.011 logMARStandard Deviation 0.1118
Day 1 PostoperativeUncorrected Visual Acuity (UCVA)Right eye (OD)0.043 logMARStandard Deviation 0.1469
Day 1 PostoperativeUncorrected Visual Acuity (UCVA)Left eye (OS)0.038 logMARStandard Deviation 0.1182
Month 1 PostoperativeUncorrected Visual Acuity (UCVA)Both eyes (OU)-0.070 logMARStandard Deviation 0.0853
Month 1 PostoperativeUncorrected Visual Acuity (UCVA)Right eye (OD)-0.021 logMARStandard Deviation 0.1269
Month 1 PostoperativeUncorrected Visual Acuity (UCVA)Left eye (OS)-0.029 logMARStandard Deviation 0.1131
Month 3 PostoperativeUncorrected Visual Acuity (UCVA)Right eye (OD)-0.024 logMARStandard Deviation 0.1123
Month 3 PostoperativeUncorrected Visual Acuity (UCVA)Both eyes (OU)-0.085 logMARStandard Deviation 0.0786
Month 3 PostoperativeUncorrected Visual Acuity (UCVA)Left eye (OS)-0.027 logMARStandard Deviation 0.1129
Month 6 PostoperativeUncorrected Visual Acuity (UCVA)Left eye (OS)-0.045 logMARStandard Deviation 0.1116
Month 6 PostoperativeUncorrected Visual Acuity (UCVA)Right eye (OD)-0.041 logMARStandard Deviation 0.0982
Month 6 PostoperativeUncorrected Visual Acuity (UCVA)Both eyes (OU)-0.084 logMARStandard Deviation 0.0858
Month 12 PostoperativeUncorrected Visual Acuity (UCVA)Both eyes (OU)-0.134 logMARStandard Deviation 0.0793
Month 12 PostoperativeUncorrected Visual Acuity (UCVA)Right eye (OD)-0.059 logMARStandard Deviation 0.1269
Month 12 PostoperativeUncorrected Visual Acuity (UCVA)Left eye (OS)-0.067 logMARStandard Deviation 0.099
Secondary

Wavefront Aberrometry

Wavefront aberrations (optical imperfections of the eye that prevent light from focusing perfectly on the retina, resulting in defects in the visual image) were measured using a commercially available system. Higher order aberrations (i.e., spherical aberrations, coma, and trefoil) are defined as optical imperfections which cannot be corrected by any reliable means of present technology.

Time frame: Operation/Surgery (Day 1), Month 1 Postoperative, Month 6 Postoperative, Month 12 Postoperative

Population: This analysis population includes all subjects with 1 month post-operative measurements of the primary efficacy endpoint with data at the specific time point.

ArmMeasureGroupValue (MEAN)Dispersion
WaveLight Refractive SuiteWavefront AberrometryTotal Higher Order RMS, Right Eye0.37 micrometersStandard Deviation 0.138
WaveLight Refractive SuiteWavefront AberrometryTotal Higher Order RMS, Left eye0.40 micrometersStandard Deviation 0.246
WaveLight Refractive SuiteWavefront AberrometrySpherical Aberration, Right Eye0.0824 micrometersStandard Deviation 0.13093
WaveLight Refractive SuiteWavefront AberrometrySpherical Aberration, Left Eye0.0851 micrometersStandard Deviation 0.12651
WaveLight Refractive SuiteWavefront AberrometryComa, Right Eye0.2059 micrometersStandard Deviation 0.1142
WaveLight Refractive SuiteWavefront AberrometryComa, Left Eye0.2040 micrometersStandard Deviation 0.1654
WaveLight Refractive SuiteWavefront AberrometryTrefoil, Right Eye0.1798 micrometersStandard Deviation 0.12264
WaveLight Refractive SuiteWavefront AberrometryTrefoil, Left Eye0.2192 micrometersStandard Deviation 0.18534
Day 1 PostoperativeWavefront AberrometryComa, Left Eye0.2950 micrometersStandard Deviation 0.16431
Day 1 PostoperativeWavefront AberrometryComa, Right Eye0.3656 micrometersStandard Deviation 0.34574
Day 1 PostoperativeWavefront AberrometryTotal Higher Order RMS, Left eye0.56 micrometersStandard Deviation 0.293
Day 1 PostoperativeWavefront AberrometryTrefoil, Left Eye0.2330 micrometersStandard Deviation 0.21332
Day 1 PostoperativeWavefront AberrometryTrefoil, Right Eye0.2316 micrometersStandard Deviation 0.24752
Day 1 PostoperativeWavefront AberrometrySpherical Aberration, Left Eye0.1614 micrometersStandard Deviation 0.20808
Day 1 PostoperativeWavefront AberrometrySpherical Aberration, Right Eye0.1399 micrometersStandard Deviation 0.23398
Day 1 PostoperativeWavefront AberrometryTotal Higher Order RMS, Right Eye0.64 micrometersStandard Deviation 0.517
Month 1 PostoperativeWavefront AberrometryTrefoil, Right Eye0.2440 micrometersStandard Deviation 0.22987
Month 1 PostoperativeWavefront AberrometrySpherical Aberration, Right Eye0.1646 micrometersStandard Deviation 0.20307
Month 1 PostoperativeWavefront AberrometrySpherical Aberration, Left Eye0.1727 micrometersStandard Deviation 0.21057
Month 1 PostoperativeWavefront AberrometryComa, Right Eye0.3306 micrometersStandard Deviation 0.34061
Month 1 PostoperativeWavefront AberrometryComa, Left Eye0.2927 micrometersStandard Deviation 0.19461
Month 1 PostoperativeWavefront AberrometryTrefoil, Left Eye0.2400 micrometersStandard Deviation 0.22751
Month 1 PostoperativeWavefront AberrometryTotal Higher Order RMS, Right Eye0.60 micrometersStandard Deviation 0.445
Month 1 PostoperativeWavefront AberrometryTotal Higher Order RMS, Left eye0.57 micrometersStandard Deviation 0.318
Month 3 PostoperativeWavefront AberrometrySpherical Aberration, Right Eye0.1619 micrometersStandard Deviation 0.19886
Month 3 PostoperativeWavefront AberrometrySpherical Aberration, Left Eye0.1954 micrometersStandard Deviation 0.1835
Month 3 PostoperativeWavefront AberrometryTotal Higher Order RMS, Left eye0.58 micrometersStandard Deviation 0.375
Month 3 PostoperativeWavefront AberrometryTotal Higher Order RMS, Right Eye0.65 micrometersStandard Deviation 0.601
Month 3 PostoperativeWavefront AberrometryComa, Right Eye0.3416 micrometersStandard Deviation 0.27229
Month 3 PostoperativeWavefront AberrometryTrefoil, Left Eye0.2403 micrometersStandard Deviation 0.20733
Month 3 PostoperativeWavefront AberrometryTrefoil, Right Eye0.2708 micrometersStandard Deviation 0.51291
Month 3 PostoperativeWavefront AberrometryComa, Left Eye0.2858 micrometersStandard Deviation 0.18065

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026